Expression of PKA inhibitor (PKI) gene abolishes cAMP-mediated protection to endothelial barrier dysfunction

American Journal of Physiology - Cell Physiology

Volumn 277, Issue 3 46-3, 1999, Pages

  Lum, Hazel ^a   Jaffe, H Ari ^b   Schulz, Irena T ^a   Masood, Anwar ^b   RayChaudhury, Amlan ^a   Green, Richard D ^c  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Department of Medicine ^*  (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Adenovirus; cAMP dependent protein kinase; Endothelial permeability

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; LUCIFERASE; VIRUS VECTOR;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0032861251     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1999.277.3.c580     Document Type: Article

References (10)

1. Ades, E. W., F. J. Candal, R. A. Swerlick, V. G. George, S. Summers, D. C. Bosse, and T. J. Lawley. HMEC-1 - establishment of an immortalized human microvascular endothelial cell line. J. Invest. Dermatol. 99: 683-690, 1992.
2. Adkins, W. K., J. W. Barnard, S. May, A. F. Seibert, J. Haynes, and A. E. Taylor. Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capillary injury. J. Appl. Physiol. 72:492-497, 1992.
3. Amerongen, G. V., R. Draijer, M. A. Vermeer, and V. M. van Hinsbergh. Transient and prolonged increase in endothelial permeability induced by histamine and thrombin - role of protein kinases, calcium, and RhoA. Circ. Res. 83:1115-1123, 1998.
4. Asai, T., S. Pelzer, and T. F. McDonald. Cyclic AMP-independent inhibition of cardiac calcium current by forskolin. Mol. Pharmacol. 50:1262-1272, 1996.
5. 2-adrenergic receptor agonist formoterol reduces microvascular leakage by inhibiting endothelial gap formation. Am. J. Physiol. 266 (Lung Cell. Mol. Physiol. 10): L461-L468, 1994.
6. Barnard, J. W., A. F. Seibert, V. R. Prasad, D. A. Smart, S. J. Strada, A. E. Taylor, and W. J. Thompson. Reversal of pulmonary capillary ischemia-reperfusion injury by rolipram, a cAMP phosphodiesterase inhibitor. J. Appl. Physiol. 77: 774-781, 1994.
7. Brody, S. L., and R. G. Crystal. Adenovirus-mediated in vivo gene transfer. Ann. NY Acad. Sci. 716:90-101, 1994.
8. Casnocha, S.A., S. G. Eskin, E. R. Hall, and L. V. McIntire. Permeability of human endothelial monolayers: effect of vasoactive agonists and cAMP. J. Appl. Physiol. 67:1997-2005, 1989.
9. Cauthron, R. D., K. B. Carter, S. Liauw, and R. A. Steinberg. Physiological phosphorylation of protein kinase A at Thr-197 is by a protein kinase A kinase. Mol. Cell. Biol. 18: 1416-1423, 1998.
10. Scott, J. D., E. H. Fischer, K. Takio, J. G. Demaille, and E. G. Krebs. Amino acid sequence of the heat-stable inhibitor of the cAMP-dependent protein kinase from rabbit skeletal muscle. Proc. Natl. Acad. Sci. USA 82:5732-5736, 1985.